
Tacopip 4000mg/500mg Injection
Marketer
Anant Remedies
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tacopip 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by a medical professional, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on illness severity, requiring precise adherence to their prescribed regimen. Common adverse effects may include nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or redness are also possible. Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions; your doctor may adjust the dosage or select an alternative medication. While generally safe under medical supervision, its use during pregnancy or breastfeeding requires physician approval.
Uses of Tacopip 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tacopip 4000mg/500mg Injection:
Administering this medication will be done by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Tacopip 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tacopip 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tacopip 4000mg/500mg Injection works:
The injectable formulation Tacopip, containing 4000mg of piperacillin and 500mg of tazobactam, combines an antibiotic with a resistance-modifying agent. Piperacillin's antibacterial action disrupts bacterial cell wall synthesis, compromising their viability. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial defenses, thereby bolstering piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Tacopip 4000mg/500mg Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Tacopip, 4000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Tacopip 4000mg/500mg Injection while breastfeeding presents minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent danger to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tacopip 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Tacopip 4000mg/500mg Injection to individuals with impaired renal function requires careful consideration. Dosage modification for Tacopip 4000mg/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tacopip 4000mg/500mg Injection in individuals with hepatic impairment appears to pose minimal risk. Preliminary findings indicate that dose modification for Tacopip 4000mg/500mg Injection might be unnecessary in such cases. However, medical advice should be sought.
What if you forget to take Tacopip 4000mg/500mg Injection :
Omit a Tacopip 4000mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Tacopip 4000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Drugs to combat infection |
